Get startedLog in
    Picture of Acadia Pharmaceuticals logo

    ACAD — Acadia Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapNeutral
    All News

    Brief: Acadia Pharmaceuticals Announces Exclusive License Agreement With Saniona For SAN711

    Picture of Acadia Pharmaceuticals logoAcadia Pharmaceuticals
    26/11/2024 22:29
    Nov 26 (Reuters) - ACADIA Pharmaceuticals Inc  ACAD.O :
    * ACADIA PHARMACEUTICALS ANNOUNCES EXCLUSIVE LICENSE
AGREEMENT
WITH SANIONA FOR SAN711
    * ACADIA PHARMACEUTICALS INC - TO INITIATE PHASE 2 STUDY OF
SAN711
IN 2026
    * ACADIA PHARMACEUTICALS INC - SANIONA TO RECEIVE $28
MILLION
UPFRONT PLUS UP TO $582 MILLION IN MILESTONES
    * ACADIA PHARMACEUTICALS INC - SANIONA ELIGIBLE FOR TIERED
ROYALTIES ON NET SALES OF SAN711
    * ACADIA PHARMACEUTICALS INC - SANIONA TO RECEIVE UP TO $147
MILLION FOR DEVELOPMENT AND COMMERCIAL MILESTONES

Source text:  ID:nBwYfhx8a 
Further company coverage:  ACAD.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Acadia Pharmaceuticals

    See all news